FNY Managed Accounts’s Omega Protein OME Stock Holding History

FNY Managed Accounts’s Portfolio OME Stock Details OME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-1	Closed	–	–	792
2017 Q1	$0	Buy	+1	New	+$23	﹤0.01%	776

Other funds holding OME

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

FNY Managed Accounts's OME Position: Q2 2017 in Review

FNY Managed Accounts sold out of Omega Protein (OME) in Q2 2017, closing a stake of 1 share.

FNY Managed Accounts first reported a position in OME in Q1 2017 and held it in 1 quarter. The position peaked at $0 in Q1 2017. 140 funds tracked by Wall St. Rank hold OME as of Q2 2017.

FNY Managed Accounts reported no remaining Omega Protein position as of Q2 2017 after selling out during the quarter.
FNY Managed Accounts sold 1 Omega Protein share in Q2 2017.
FNY Managed Accounts first reported a position in Omega Protein in Q1 2017 and held it in 1 quarter.
FNY Managed Accounts's Omega Protein position peaked at $0 in Q1 2017.
140 funds tracked by Wall St. Rank held Omega Protein as of Q2 2017.

Based on FNY Managed Accounts's 13F filing for Q2 2017, filed 10 Aug 2017.